Hepatocellular carcinoma as an emerging morbidity in the thalassemia syndromes: A comprehensive review-Reference-Cited by-同舟云学术

Hepatocellular carcinoma as an emerging morbidity in the thalassemia syndromes: A comprehensive review

Published:2016-12-01 Issue:5 Volume:123 Page:751-758
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Moukhadder Hassan M.¹,Halawi Racha²,Cappellini Maria Domenica³⁴,Taher Ali T.¹

Affiliation:

1. Division of Hematology/Oncology, Department of Internal Medicine; American University of Beirut Medical Center; Beirut Lebanon

2. Department of Internal Medicine; Emory University School of Medicine; Atlanta Georgia

3. Department of Internal Medicine; Foundation of the Scientific Institute for Research, Hospitalization, and Health Care (IRCCS), Ca' Granda Ospedale Maggiore Polyclinic; Milan Italy

4. Department of Clinical Sciences and Community Health; University of Milan; Milan Italy

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.30462/fullpdf

Reference76 articles.

1. The Thalassaemia Syndromes

2. Non-transfusion-dependent thalassemias;Musallam;Haematologica,2013

3. Hepatocellular carcinoma in thalassemia: a critical review;Mancuso;World J Hepatol,2010

4. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine;Borgna-Pignatti;Haematologica,2004

5. Management of hepatocellular carcinoma: enlightening the gray zones;Mancuso;World J Hepatol,2013

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma;Journal of Cancer Research and Clinical Oncology;2023-08-22

2. Insights into Hepatocellular Carcinoma in Patients with Thalassemia: From Pathophysiology to Novel Therapies;International Journal of Molecular Sciences;2023-08-10

3. The impact of HCV chronic positivity and clearance on extrahepatic morbidity in thalassemia major patients: an observational study from MIOT Network;European Journal of Internal Medicine;2023-08

4. Activating the Hippo pathway by nevadensin overcomes Yap-drived resistance to sorafenib in hepatocellular carcinoma;Discover Oncology;2023-05-27

5. Hepatitis C and Thalassemia: A Story with (Almost) a Happy Ending;Pathogens;2023-05-05